Your browser doesn't support javascript.
loading
Fetal fraction evaluation in non-invasive prenatal screening (NIPS).
Hestand, Matthew S; Bessem, Mark; van Rijn, Peter; de Menezes, Renee X; Sie, Daoud; Bakker, Ingrid; Boon, Elles M J; Sistermans, Erik A; Weiss, Marjan M.
Afiliação
  • Hestand MS; Department of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
  • Bessem M; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • van Rijn P; Department of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
  • de Menezes RX; Department of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
  • Sie D; Department of Epidemiology and Biostatistics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
  • Bakker I; Department of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
  • Boon EMJ; Department of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
  • Sistermans EA; Department of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
  • Weiss MM; Department of Clinical Genetics, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Eur J Hum Genet ; 27(2): 198-202, 2019 02.
Article em En | MEDLINE | ID: mdl-30254213
ABSTRACT
An important factor in quality control of non-invasive prenatal screening (NIPS) or testing (NIPT) is a sufficient percentage of fetal DNA to avoid false-negative results. Here we evaluate 14,379 shallow whole-genome sequenced diagnostic NIPS samples, as well as negative controls, for both technical and biological factors that can influence fetal fraction and its assessment. Technically, bioinformatics analyses can have a profound impact on fetal fraction determination. We found best performance for fetal fraction determination with the Y chromosome based tool DEFRAG for male fetuses and the count based tool SeqFF for female fetuses. Biologically, gestational age of up to 21 weeks and maternal age had no influence on fetal fraction, while an increase in weight and BMI had a negative influence on fetal fraction. While a trend was observed, no statistically significant difference in fetal fraction was found between trisomy and normal samples. Overall, these results confirm the influence of biological factors and give insight into technical factors that can affect fetal fractions in NIPS.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diagnóstico Pré-Natal / Testes Genéticos / Transtornos Cromossômicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diagnóstico Pré-Natal / Testes Genéticos / Transtornos Cromossômicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda